key: cord-0992021-chv8gwo1 authors: Perera, R. A.; Tso, E.; Tsang, O. T.; Tsang, D. N.; Fung, K.; Leung, Y. W.; Chin, A. W.; Chu, D. K.; Cheung, S. M.; Poon, L. L.; Chuang, V. W.; Peiris, M. title: SARS-CoV-2 virus culture from the upper respiratory tract: Correlation with viral load, subgenomic viral RNA and duration of illness. date: 2020-07-09 journal: nan DOI: 10.1101/2020.07.08.20148783 sha: 32910d3a1e246f83e129b383d69c644ab541f1ab doc_id: 992021 cord_uid: chv8gwo1 In 68 respiratory specimens from a cohort of 35 COVID-19 patients, 32 of them with mild disease, we found SARS coronavirus-2 virus culture and sub-genomic RNA was rarely detectable beyond 8 days after onset of illness although virus RNA by RT-PCR remained detectable for many weeks. SARS-CoV-2 emerged in late 2019 to cause a pandemic of severe respiratory disease with major impact on global health and economies. Virus RNA may be detectable by RT-PCR long after clinical recovery, some patients remaining positive for three weeks or longer (1, 2) . Similar findings were seen with SARS in 2003 (3) . A significant proportion of transmission occurs prior to and soon after onset of illness (4) . However, the duration of contagiousness after the onset of clinical symptoms remains poorly understood. This is relevant to determining policy on discharge of patients from containment in hospitals. Viral RNA detection by RT-PCR does not prove the presence of infectious virus whereas culture isolation of virus is a better indication of contagiousness. Recent studies on experimentally infected hamsters showed efficient transmission of SARS-CoV-2 to contact hamsters on day 1 after challenge when virus culture was positive in the nasal washes but there was no transmission by day 6 when nasal washes were culture negative although viral load determined by RT-PCR was still high (>6.0 log10 RNA copies per mL) (5) . Thus virus culture may be a better surrogate for transmissibility. We attempted virus isolation in 68 specimens collected from 35 patients collected at different times after symptom onset to define the kinetics of culturable virus in upper respiratory specimens of patients with RT-PCR confirmed COVID-19 disease, those specimens with viral load ≥5 log10 also being examined for detection of sub-genomic viral RNA (sgRNA). Patients were diagnosed as COVID-19 by RT-PCR at individual hospitals. Follow up specimens were sent to the School of Public Health, The University of Hong Kong for virus All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 9, 2020. Sixty eight specimens from thirty five patients were studied. Patients with prolonged virus shedding (10 remaining virus RNA positive for >30 days) and those re-admitted because of RT-PCR positivity detected after discharge (N=6) were oversampled. Patient-age ranged from 17 to 75 years (median 38 years) and 44 of them were male (Table) . Nine patients had underlying co-morbidities, including diabetes mellitus, hypertension, ischemic heart disease, atrial fibrillation, chronic obstructive airways disease, carcinoma of the lung, mild renal dysfunction and chronic hepatitis B carrier. None of the patients were immunocompromised. Three patients were asymptomatic, twenty nine patients had mild clinical illness (mild influenza-like illness symptoms, not requiring supplemental oxygen, or requiring < 3 liters / minute), two patients were critical (intubated, required ECMO or in shock) and one died. For asymptomatic patients, days after onset was estimated as days after first RT-PCR detection. Specimens submitted for virus culture were nasopharyngeal aspirates combined with throat swab (n=49), nasopharyngeal aspirate (n=2), nasopharyngeal swab combined with throat swab (n=3), nasopharyngeal swab (n=2), sputum (n=11) and saliva (n=1). The duration after onset of illness to specimen collection ranged from 1 to 67 days. The median age of the culture positive and negative patients was 39 and 38 years, respectively. SARS-CoV-2 N gene copy number in the specimens ranged from 9.5 log10 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 9, 2020. . https://doi.org/10.1101/2020.07.08.20148783 doi: medRxiv preprint copies per mL to undetectable (limit of detection: 10 copies per mL) (Figure 1) , with the mean viral load in the culture positive and negative samples being 7.6 and 3.8 log10 copies per mL of specimen, respectively. Virus was cultured from 12 of 17 specimens with virus load ranging from 7.0-9.5 log10 copies per mL of specimen, 3 of 11 specimens with viral load ranging from 6.0-6.99 log10 copies per mL, 1 of seven specimens with viral load ranging from 5.0-5.99 log10 copies per mL and from none of 33 specimens with viral load <5log10 copies per mL (Table) ( Figure 1 ). Virus isolation was successful in 8 of 15 specimens collected in the first two days after onset of symptoms, 3 of 8 specimens on day 3-4 after onset, 3 of 10 specimens on day 5-6 after onset, 2 of 5 on days 7-8 after onset and 0 (0%) of 30 specimens collected from day 9 or later after onset of illness (Table) (Figure 1 ). Sub-genomic RNA (sgRNA) provides evidence of replicative intermediates of the virus rather than residual viral RNA. Detection of virus sgRNA was attempted in 33 of the 35 the specimens with viral load ≥5.0 log10 virus genome copies per mL of clinical specimen, two specimens had insufficient specimen for this additional testing. Of 33 specimens tested for both sgRNA and virus culture, both were positive in 12 (36.3%) specimens, both were negative in 36.4%, sgRNA was positive and culture negative in 7 (21.2%) while culture was positive and sgRNA was negative in 2 (6.1%), the association between virus culture and sgRNA being significant (Chi squared test with Yates correction p=0.014). Virus sgRNA was detectable in 18 (81.8%) of 22 specimens collected 8 days or less after symptom onset and in 1 (9.1%) of 11 specimens collected 9 or more days after onset of disease (Chi squared test with Yates correction p=0.0003) (Figure 2 ). All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 9, 2020. . https://doi.org/10.1101/2020.07.08.20148783 doi: medRxiv preprint In a cohort of predominantly mild COVID-19 patients, our findings suggested that virus isolation and sgRNA detection was possible mainly within the first eight days after onset of illness and from specimens with ≥6 log10 virus N gene copies per mL of clinical specimen. Although there were five specimens with viral load ≥6 log10 virus N gene copies per mL later than 50 days after onset of illness, none of these yielded culturable virus or virus sgRNA. Thus viral load itself was not predictive of presence of infectious virus or sgRNA. We did not carry out serological testing in parallel with viral culture but data on a larger cohort of patients followed up in Hong Kong showed that most patients had detectable (titer ≥1:10) plaque reduction neutralization antibody titres after day 9 of illness (7) . There are two other studies of virus culture on mild or moderately ill patients and virus culture was successful only within the first 9 days after onset of illness (8, 9) . Patients who are severely ill and immunocompromised may shed infectious virus for much longer periods of time (10) . Taken together previous data, our findings suggest that patients with mild or moderate illness may be less contagious after eight days after symptom onset. Mildly ill patients who have clinically recovered and not immunocompromised may be discharged from containment after 9 days or more after symptom onset, while ensuring that they are not being discharged into settings with other highly vulnerable individuals (e.g. old age care homes). These findings support the recent change in the WHO guidelines for releasing COVID-19 patients from isolation; viz. 10 days after symptom onset and at least 3 additional days without symptoms (11) . All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 9, 2020. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 9, 2020. . https://doi.org/10.1101/2020.07.08.20148783 doi: medRxiv preprint Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: A descriptive study Detection of SARS coronavirus in patients with suspected SARS Temporal dynamics in viral shedding and transmissibility of COVID-19 Pathogenesis and transmission of SARS-CoV-2 in golden hamsters Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Virological assessment of hospitalized patients with COVID-2019 Predicting infectious SARS-CoV-2 from diagnostic samples Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants World Health Organization. Criteria for rleasing CODI-19 patients from isolation All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted July 9, 2020. . https://doi.org/10.1101/2020.07.08.20148783 doi: medRxiv preprint All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted July 9, 2020. . https://doi.org/10.1101/2020.07.08.20148783 doi: medRxiv preprint All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted July 9, 2020. . https://doi.org/10.1101/2020.07.08.20148783 doi: medRxiv preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted July 9, 2020. . https://doi.org/10.1101/2020.07.08.20148783 doi: medRxiv preprint All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted July 9, 2020. . https://doi.org/10.1101/2020.07.08.20148783 doi: medRxiv preprint